Development of the Human Infant Intestinal Microbiota
Almost immediately after a human being is born, so too is a new microbial ecosystem, one that resides in that person's gastrointestinal tract. Although it is a universal and integral part of human biology, the temporal progression of this process, the sources of the microbes that make up the ecosystem, how and why it varies from one infant to another, and how the composition of this ecosystem influences human physiology, development, and disease are still poorly understood. As a step toward systematically investigating these questions, we designed a microarray to detect and quantitate the small subunit ribosomal RNA (SSU rRNA) gene sequences of most currently recognized species and taxonomic groups of bacteria. We used this microarray, along with sequencing of cloned libraries of PCR-amplified SSU rDNA, to profile the microbial communities in an average of 26 stool samples each from 14 healthy, full-term human infants, including a pair of dizygotic twins, beginning with the first stool after birth and continuing at defined intervals throughout the first year of life. To investigate possible origins of the infant microbiota, we also profiled vaginal and milk samples from most of the mothers, and stool samples from all of the mothers, most of the fathers, and two siblings. The composition and temporal patterns of the microbial communities varied widely from baby to baby. Despite considerable temporal variation, the distinct features of each baby's microbial community were recognizable for intervals of weeks to months. The strikingly parallel temporal patterns of the twins suggested that incidental environmental exposures play a major role in determining the distinctive characteristics of the microbial community in each baby. By the end of the first year of life, the idiosyncratic microbial ecosystems in each baby, although still distinct, had converged toward a profile characteristic of the adult gastrointestinal tract.
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from patients with lung and kidney cancers and found that nonresponding patients had low levels of the bacterium Akkermansia muciniphila. Oral supplementation of the bacteria to antibiotic-treated mice restored the response to immunotherapy. Matson et al. and Gopalakrishnan et al. studied melanoma patients receiving PD-1 blockade and found a greater abundance of “good” bacteria in the guts of responding patients. Nonresponders had an imbalance in gut flora composition, which correlated with impaired immune cell activity. Thus, maintaining healthy gut flora could help patients combat cancer. Science, this issue p. 91, p. 104, p. 97; see also p. 32 Gut bacteria influence patient response to cancer therapy. Preclinical mouse models suggest that the gut microbiome modulates tumor response to checkpoint blockade immunotherapy; however, this has not been well-characterized in human cancer patients. Here we examined the oral and gut microbiome of melanoma patients undergoing anti–programmed cell death 1 protein (PD-1) immunotherapy (n = 112). Significant differences were observed in the diversity and composition of the patient gut microbiome of responders versus nonresponders. Analysis of patient fecal microbiome samples (n = 43, 30 responders, 13 nonresponders) showed significantly higher alpha diversity (P < 0.01) and relative abundance of bacteria of the Ruminococcaceae family (P < 0.01) in responding patients. Metagenomic studies revealed functional differences in gut bacteria in responders, including enrichment of anabolic pathways. Immune profiling suggested enhanced systemic and antitumor immunity in responding patients with a favorable gut microbiome as well as in germ-free mice receiving fecal transplants from responding patients. Together, these data have important implications for the treatment of melanoma patients with immune checkpoint inhibitors.
cloud computing social network regression model gene expression sample size confidence interval logistic regression social science systematic review linear regression model cloud datum xml document immune system carbon dioxide amino acid logistic regression model keyword search mental model process analysi background and objective encrypted datum quantitative assessment plant growth escherichia coli sequence analysi discourse analysi scientific publication channel condition immune response choice behavior programming paradigm natural selection organic matter odds ratio social structure microbial community signal transduction membrane protein encrypted cloud datum encrypted cloud lactic acid plant root oral cavity quorum sensing gene transfer antibiotic resistance cardiac surgery critical discourse analysi dental cary cell count marine ecosystem recombinant dna oxidative stres critical discourse aquatic ecosystem horizontal gene transfer bibliographic reference ribosomal rna horizontal gene lactic acid bacterium plasma membrane acute kidney acute kidney injury resistance gene cell survival genetic selection acid bacterium physiological aspect gram-negative bacterium social characteristic social inequality ranked keyword search ranked keyword abbott laboratory dental plaque oligonucleotide probe base pairing resistant bacterium antibiotic resistance gene lactobacillus acidophilu gram-positive bacterium genetic heterogeneity biofilm development nitrogen cycle microbial biofilm transcription, genetic interface device component metabolic process, cellular national origin biological adaptation to stress clone cell ethanol 0.62 ml/ml topical gel clinical act of insertion genetic translation proces hereditary disease greater than cognition disorder phobia, social nucleic acid hybridization gel electrophoresis (lab technique) stimulation (motivation) meta analysis (statistical procedure) the superficial genome, bacterial amino acid metabolism, inborn error denial (psychology) immunoglobulin lambda-chain fifty nine reservoir device component document completion status - documented gastrointestinal tract structure genus (mathematics) domain of discourse phylum (taxon) intestinal microbiome microbiota (plant) genus mycobacterium antibiotic resistance, microbial ammonia measurement ammonia oxidation models, mental anabolic steroid actinobacteria clas fecal microbiota transplantation kidney failure, acute gene transfer, horizontal ferrosoferric oxide dennis fairclough ruth teitelbaum shoshana wodak excretory function entity name part qualifier - adopted cessation of life anatomical layer biopolymer sequencing ephrin type-b receptor 1, human one thousand copy (object) review [publication type] promotion (action) pathogenic organism